02/09/2024 2:06 PM | Galecto (Subject) Otto Erik (Filed by)
| Form SCHEDULE 13G/A | |
12/21/2023 3:30 PM | Galecto (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/23/2023 8:00 AM | Galecto (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/03/2023 10:29 AM | Galecto (Subject) Otto Erik (Filed by)
| Form SC 13G | |
10/02/2023 8:55 PM | Galecto (Subject) ORBIMED CAPITAL LLC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/02/2023 8:49 PM | Galecto (Subject) ORBIMED ADVISORS LLC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/02/2023 8:50 PM | Galecto (Subject) ORBIMED ADVISORS LLC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
|
10/02/2023 8:53 PM | Galecto (Subject) OrbiMed Advisors Israel II Ltd (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/02/2023 3:00 PM | Galecto (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/18/2023 3:19 PM | Galecto (Subject) ORBIMED ADVISORS LLC (Filed by)
| Form SC 13D/A | |
09/05/2023 3:20 PM | Galecto (Subject) ORBIMED ADVISORS LLC (Filed by)
| Form SC 13D/A | |
08/30/2023 4:02 PM | Galecto (Subject) ORBIMED ADVISORS LLC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/30/2023 4:08 PM | Galecto (Subject) OrbiMed Advisors Israel II Ltd (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/30/2023 4:17 PM | Galecto (Subject) ORBIMED CAPITAL LLC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/21/2023 7:14 PM | Galecto (Subject) ORBIMED ADVISORS LLC (Reporting)
| Form 144/A | |
08/21/2023 3:55 PM | Galecto (Subject) ORBIMED ADVISORS LLC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/21/2023 3:57 PM | Galecto (Subject) ORBIMED ADVISORS LLC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/21/2023 3:39 PM | Galecto (Subject) OrbiMed Advisors Israel II Ltd (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/21/2023 3:47 PM | Galecto (Subject) ORBIMED CAPITAL LLC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/17/2023 3:40 PM | Galecto (Issuer) OrbiMed Advisors Israel II Ltd (Reporting) ORBIMED ADVISORS LLC (Reporting) OrbiMed Capital GP VII LLC (Reporting) OrbiMed Genesis GP LLC (Reporting) OrbiMed Israel GP II, L.P. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/17/2023 3:30 PM | Galecto (Subject) ORBIMED ADVISORS LLC (Filed by)
| Form SC 13D/A | |
08/15/2023 5:22 PM | Galecto (Subject) ORBIMED ADVISORS LLC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/15/2023 5:25 PM | Galecto (Subject) OrbiMed Advisors Israel II Ltd (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/15/2023 5:29 PM | Galecto (Subject) ORBIMED CAPITAL LLC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/15/2023 5:19 PM | Galecto (Subject) ORBIMED ADVISORS LLC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/15/2023 7:00 AM | Galecto (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/31/2023 5:29 PM | Galecto (Subject) ORBIMED ADVISORS LLC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/31/2023 5:31 PM | Galecto (Subject) ORBIMED ADVISORS LLC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/31/2023 5:36 PM | Galecto (Subject) OrbiMed Advisors Israel II Ltd (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/31/2023 5:38 PM | Galecto (Subject) ORBIMED CAPITAL LLC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/31/2023 3:00 PM | Galecto (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/17/2023 3:11 PM | Galecto (Subject) ORBIMED ADVISORS LLC (Filed by)
| Form SC 13D/A | |
07/17/2023 3:13 PM | Galecto (Issuer) OrbiMed Advisors Israel II Ltd (Reporting) ORBIMED ADVISORS LLC (Reporting) OrbiMed Capital GP VII LLC (Reporting) OrbiMed Genesis GP LLC (Reporting) OrbiMed Israel GP II, L.P. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/13/2023 7:07 PM | Galecto (Subject) ORBIMED CAPITAL LLC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/13/2023 7:09 PM | Galecto (Subject) OrbiMed Advisors Israel II Ltd (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/13/2023 7:00 PM | Galecto (Subject) ORBIMED ADVISORS LLC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/13/2023 7:04 PM | Galecto (Subject) ORBIMED ADVISORS LLC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |